Medtronic PLC (MDT)

79.70
NYSE : Health Care
Prev Close 79.53
Day Low/High 79.11 / 79.89
52 Wk Low/High 69.35 / 89.72
Avg Volume 4.47M
Exchange NYSE
Shares Outstanding 1.35B
Market Cap 107.73B
EPS 2.90
P/E Ratio 26.78
Div & Yield 1.84 (2.30%)

Latest News

FDA Approves Abbott Heart Device, Stock Rises

FDA Approves Abbott Heart Device, Stock Rises

The HeartMate 3 received regulatory approval.

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

Jim Cramer says commodities, China's strength, global market gains and more all point to keeping this rally alive.

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

America's biggest hedge funds are worth over $6 trillion combined, and here are the most common stocks they're selling.

Cramer: This Rally Isn't Without Meaning

Cramer: This Rally Isn't Without Meaning

Accentuate the positives, ignore the negatives.

Cramer: This Rally Is Just the Reverse of the Selloff

Cramer: This Rally Is Just the Reverse of the Selloff

It is tech that really is screaming to be noticed.

Afghanistan and Jackson Hole - 5 Things You Must Know Before the Market Opens

Afghanistan and Jackson Hole - 5 Things You Must Know Before the Market Opens

U.S. stock futures rise Tuesday, and shares in Europe and Asia move higher.

Novartis AG, Sirius XM Radio, Coupa Software: 'Mad Money' Lightning Round

Novartis AG, Sirius XM Radio, Coupa Software: 'Mad Money' Lightning Round

Jim Cramer is bullish on Novartis AG, Sirius XM Radio, Coupa Software and Juno Therapeutics.

August's Inexplicable Selloffs Are Here: Cramer's 'Mad Money' Recap (8/17/17)

August's Inexplicable Selloffs Are Here: Cramer's 'Mad Money' Recap (8/17/17)

Jim Cramer says the calendar and the momentum holders are coalescing to produce selling. Here's what investors should do about it.

EY's Greene Sees More Med Tech, CRO Deals Ahead

EY's Greene Sees More Med Tech, CRO Deals Ahead

Consolidation, improving equity prices and sufficient firepower for deals continue to fuel med tech M&A, according to EY's Jeff Greene.

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course

Identifying this week's bullish and bearish reversal patterns.

Transports Finally Get Some Attention

ETF may be in for a bounce.

Cardinal Health Selling China Business Worth Up to $1.5 Billion

Cardinal Health Selling China Business Worth Up to $1.5 Billion

State-backed Chinese pharmaceutical companies have shown interest.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Medtronic Plc And Advises Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces An Investigation Of Medtronic Plc And Advises Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT) concerning possible violations of federal securities laws.

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Medtronic Plc

INVESTOR ALERT: Goldberg Law PC Announces An Investigation Of Medtronic Plc

Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT).

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Medtronic Plc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Medtronic Plc

Levi & Korsinsky announces it has commenced an investigation of Medtronic plc ("Medtronic" or the "Company") (NYSE:MDT) concerning possible violations of federal securities laws.

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Medtronic Plc Investors

Glancy Prongay & Murray LLP Commences Investigation On Behalf Of Medtronic Plc Investors

Glancy Prongay & Murray LLP ("GPM") announces an investigation on behalf of Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT) investors concerning the Company and its officers' possible violations of...

Medtronic CFO Expects Q1 Sales at Low End of Guidance

Medtronic CFO Expects Q1 Sales at Low End of Guidance

Medtronic is still working to fill back orders.

As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals

As Treasury Moves to Bring Back Inversions, Here are 7 of the Biggest Recent Deals

The Trump administration's creep towards scrapping certain tax regulations could revive inversion deals that have allowed U.S. companies to avoid billions of dollars in taxes.

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.

IBM's Security Tie-Up With Cisco Once More Shows Big Blue's Value as a Tech Partner

IBM's Security Tie-Up With Cisco Once More Shows Big Blue's Value as a Tech Partner

Though IBM continues to face major revenue headwinds, its software and services expertise in numerous fields makes it a valuable ally to tech giants and others.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures rise Thursday but European shares fluctuate after global oil prices turn sharply lower.

Market Recon: Oil Prices and the Fed Are the Market's Guides Today

Market Recon: Oil Prices and the Fed Are the Market's Guides Today

U.S. oil producers are becoming more important in any calculation about oil prices.

Week Ahead: With Trump Out of Washington, the Focus Returns to Fed Forecasts

Week Ahead: With Trump Out of Washington, the Focus Returns to Fed Forecasts

Prepare for a week of Fedspeak as members prime markets for a potential interest rate hike in June.

TheStreet Quant Rating: B+ (Buy)